We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioCity Invests in Early-stage Precision Medicine Biotech

Product News   Aug 29, 2019

 
BioCity Invests in Early-stage Precision Medicine Biotech

Pictured L-R: Michele Hill-Perkins QMU, Pedro Cutillas QMU / Kinomica founder, Jane Theaker Kinomica CEO, Dr. Claire Brown BioCity investment director, David Britton Kinomica CSO / founder

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Mission Bio Launches Cloud-based Tool to Improve CRISPR Safety

Product News

Mission Bio has extended capabilities for its automated, cloud-based tool for designing targeted single-cell DNA custom panels, now with applications across mouse genomes and CRISPR editing.

READ MORE

BenchCel Microplate Handler for Full Workflow Automation

Product News

BioTek has announced that Agilent’s BenchCel Microplate Handler is now added to its portfolio of walkaway automated solutions.

READ MORE

Specialized MAT Reagents for Accurate and Reliable In Vitro Pyrogen Testing

Product News

Lonza and Sanquin have entered into a strategic partnership for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery Proteomics & Metabolomics Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE